双侧乳房切除术与乳腺癌死亡率
这项基于SEER数据库的队列研究纳入661270例单侧乳腺癌(0~III期)女性,按1:1:1匹配比较肿块切除术、单侧乳房切除术与双侧乳房切除术各36028例的20年累积乳腺癌死亡风险。结果显示双侧乳房切除术大幅降低对侧乳腺癌风险,但三组乳腺癌死亡率相似。
要点
- 双侧乳房切除术大幅降低对侧乳腺癌风险,但乳腺癌死亡率与肿块切除术或单侧乳房切除术相似。
- 发生对侧乳腺癌后15年累积乳腺癌死亡率为32.1%,未发生者为14.5%(HR 4.00;95%CI 3.52-4.54)。
- 三组20年乳腺癌死亡人数分别为肿块切除术组3077例(8.54%)、单侧乳房切除术组3269例(9.07%)、双侧乳房切除术组3062例(8.50%)。
核心结论
- 该队列研究提示,发生对侧乳腺癌后死于乳腺癌的风险大幅增加。
- 接受双侧乳房切除术的女性对侧乳腺癌风险大幅降低,但其死亡率与接受肿块切除术或单侧乳房切除术的患者相似。
研究设计与样本
- 这项队列研究使用监测、流行病学和最终结果(SEER)项目登记数据库,识别2000年至2019年诊断为单侧乳腺癌(浸润性癌及导管原位癌)的女性。
- 采用1:1:1匹配按手术方式生成三个规模相等且密切匹配的队列,每组36028例,随访20年观察对侧乳腺癌和乳腺癌死亡率。
- 研究样本共661270例单侧乳腺癌女性,平均(标准差)年龄58.7(11.3)岁;数据分析时间为2023年10月至2024年2月。
主要发现
- 20年随访期间,肿块切除术组观察到766例对侧乳腺癌,单侧乳房切除术组728例,双侧乳房切除术组97例。
- 肿块切除术-单侧乳房切除术组的20年对侧乳腺癌风险为6.9%(95%CI 6.1%-7.9%)。
- 发生对侧乳腺癌后15年累积乳腺癌死亡率为32.1%,未发生对侧乳腺癌者为14.5%(以对侧乳腺癌为时间依赖协变量的风险比4.00;95%CI 3.52-4.54)。
- 乳腺癌死亡人数在肿块切除术组为3077例(8.54%),单侧乳房切除术组为3269例(9.07%),双侧乳房切除术组为3062例(8.50%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The benefit of bilateral mastectomy for women with unilateral breast cancer in terms of deaths from breast cancer has not been shown. OBJECTIVES: To estimate the 20-year cumulative risk of breast cancer mortality among women with stage 0 to stage III unilateral breast cancer according to the type of initial surgery performed. DESIGN, SETTINGS, AND PARTICIPANTS: This cohort study used the Surveillance, Epidemiology, and End Results (SEER) Program registry database to identify women with unilateral breast cancer (invasive and ductal carcinoma in situ) who were diagnosed from 2000 to 2019. Three closely matched cohorts of equal size were generated using 1:1:1 matching according to surgical approach. The cohorts were followed up for 20 years for contralateral breast cancer and for breast cancer mortality. The analysis compared the 20-year cumulative risk of breast cancer mortality for women treated with lumpectomy vs unilateral mastectomy vs bilateral mastectomy. Data were analyzed from October 2023 to February 2024. EXPOSURES: Type of breast surgery performed (lumpectomy, unilateral mastectomy, or bilateral mastectomy). MAIN OUTCOMES AND MEASURES: Contralateral breast cancer or breast cancer mortality during the 20-year follow-up period among the groups treated with lumpectomy vs unilateral mastectomy vs bilateral mastectomy. RESULTS: The study sample included 661 270 women with unilateral breast cancer (mean [SD] age, 58.7 [11.3] years). After matching, there were 36 028 women in each of the 3 treatment groups. During the 20-year follow-up, there were 766 contralateral breast cancers observed in the lumpectomy group, 728 contralateral breast cancers in the unilateral mastectomy group, and 97 contralateral cancers in the bilateral mastectomy group. The 20-year risk of contralateral breast cancer was 6.9% (95% CI, 6.1%-7.9%) in the lumpectomy-unilateral mastectomy group. The cumulative breast cancer mortality was 32.1% at 15 years after developing a contralateral cancer and was 14.5% for those who did not develop a contralateral cancer (hazard ratio, 4.00; 95% CI, 3.52-4.54, using contralateral breast cancer as a time-dependent covariate). Deaths from breast cancer totaled 3077 women (8.54%) in the lumpectomy group, 3269 women (9.07%) in the unilateral mastectomy group, and 3062 women (8.50%) in the bilateral mastectomy group. CONCLUSIONS AND RELEVANCE: This cohort study indicates that the risk of dying of breast cancer increases substantially after experiencing a contralateral breast cancer. Women with breast cancer treated with bilateral mastectomy had a greatly diminished risk of contralateral breast cancer; however, they experienced similar mortality rates as patients treated with lumpectomy or unilateral mastectomy.
引用
- Giannakeas V, Lim DW, Narod SA, et al. Bilateral Mastectomy and Breast Cancer Mortality. JAMA Oncol. 2024. PMID: 39052262. doi:10.1001/jamaoncol.2024.2212
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。